Société Française de Toxicologie
Menu icoMenu232White icoCross32White

Images de la page d'accueil

Cliquez pour éditer

Ajoutez un logo, un bouton, des réseaux sociaux

Cliquez pour éditer
  • Société Française de Toxicologie
  • icoHome32Dark
    Accueil
  • Se connecter
Retour
Hugo VANKELECOM

Hugo VANKELECOM

Prof. Dr. Hugo Vankelecom is a full professor at KU Leuven (Belgium), leading a team of 15 people (PhD, postdoc, Master, technician). He is a leading expert in tissue 3D organoid modeling, thereby being the top and most visible research group in this booming field at the KU Leuven.

Vankelecom’s research is situated in women’s health (endocrine-reproductive biology and disease). The group established multiple organoid protocols and is creating organoid biobanks covering a broad spectrum of diseases. The Vankelecom group was the first to establish organoids from the womb’s lining (endometrium) and endometrial diseases, as well as from ovary tissue (cancer) and pituitary gland (mouse), all powerful tools to decipher the (patho-)biology of these essential female endocrine-reproductive organs. In addition, the team advanced the endometrial organoid tool into an innovative in vitro embryo implantation model. All these organoid models provide powerful preclinical tools for disease modeling and its mechanistic decoding, therapeutic discovery, drug screening and regenerative medicine, as well as for (repro-)toxicity screening (given the availability of the healthy control counterpart organoids). Moreover, the team is further advancing the models into composite assembloids and organ(oid-)on-chip configurations. The strong organoid expertise instigates increasing numbers of (interdisciplinary) collaborations in several domains of women’s health. Moreover, Vankelecom, together with Dr. Frauke Christ and Prof. Marianne Carlon, created the interdisciplinary ‘organoid@KUL’ platform, a vibrant ecosystem of 3D tissue modeling research and expertise bringing together all KU/UZ Leuven (and beyond) research groups interested in these cutting-edge technologies. Vankelecom is also co-founder of several KU Leuven Core Facilities (FACS, PDTX, …), and is valorising the team’s organoid results toward start-up creation (e.g. biotech start-up incorporated August 2020 through LRD aimed at improving IVF success rate using endometrial organoids (currently in stand-by); CurE-me project toward spin-off creation - KU Leuven-BioInnovation Institute (BII, Copenhagen)).

Publications - http://lirias.kuleuven.be/cv?Username=U0013533

To be followed on LinkedIn; e-mail: Hugo.vankelecom@kuleuven.be

icoLinkedin35Color icoComment35Color
icoLinkedin35Color icoComment35Color
0 commentaire(s)
ou
Connectez-vous
Aucun commentaire pour le moment.
Consultez également
Christophe DE LA ROCHE SAINT-ANDRE

Christophe DE LA ROCHE SAINT-ANDRE

Ancien normalien, Christophe de La Roche Saint-André est titulaire d’un doctorat en biologie. Il...

16 juin 2025
Fabien LAVERGNE

Fabien LAVERGNE

A compléter

5 juin 2025
Romain GRALL

Romain GRALL

Romain Grall est un pharmacien et toxicologue français, actuellement responsable du Laboratoire...

4 juin 2025
Elisabeth ELEFANT

Elisabeth ELEFANT

Praticien hospitalier à l'Université Paris Sorbonne, APHP (1981-2023) et en cumul...

3 juin 2025
Jeanne STADLER

Jeanne STADLER

Jeanne Stadler est pharmacien diplômée de la Faculté de Pharmacie de Paris. Elle a exercé comme...

3 juin 2025
Karen CHARDON

Karen CHARDON

Professeur de neurophysiologie à Amiens, co-directrice adjointe du laboratoire Péritox (UMR I01...

3 juin 2025
Hôpital Fernand-Widal - 200 rue du Faubourg Saint-Denis - 75475 Paris Cedex 10 / Contact : sft.secretariat@gmail.com
icoLinkedin24Color
  • Plan du site
  • Licences
  • Mentions légales
  • CGUV
  • Paramétrer les cookies
  • Se connecter
  • Propulsé par AssoConnect, le logiciel des associations Professionnelles